Production tips from Crystal Bio, TriLink Biotechnologies, Ginkgo Bioworks, Quantoom Biosciences, and Parexel.

In a process called deadenylation, the target mRNA is recruited by RNA-binding proteins ... scientists were able to take their work even one step further and demonstrate the potential of their ...

A new hydrophobic tag enables the high-purity production of a key intermediate in the chemical synthesis of capped mRNA and ...

In this Thought Leader article., Ian Johnston from Cytiva discusses challenges related to process development, scaling technology, regulatory approvals, and GMP guidelines.

The idea that speckles might be storage sites for spliceosomes triggered Guttman to look deeper into how nuclear organization ...

Researchers uncovered a promising target for controlling gene expression, which could impact crop resilience and human disease treatment.

Welcome to the Moderna third quarter 2024 conference call. [Operator instructions] Please be advised today's conference is ...

Working with animals, Penn researchers modified the mRNA vaccine to target C. difficile, an infection that kills 30,000 in ...

In a process called deadenylation, the target mRNA is recruited by RNA-binding proteins ... scientists were able to take their work even one step further and demonstrate the potential of their ...

For mRNA decapping by enhancing DCP2's mRNA-binding affinity and regulating distinct biological processes through DCP1a and DCP1b, human DCP1 is essential.

The Nucleic Acid Therapeutics Initiative (NATi), a national platform hosted by the Agency for Science, Technology and Research (A*STAR), officially launched the non-GMP NATi mRNA BioFoundry today.